Comparison of plasma trough concentrations of voriconazole in patients with or without comedication of ranitidine or pantoprazole

被引:5
|
作者
Heinz, W. J.
Kloeser, C.
Helle, A.
Guhl, C.
Scheuermann, S.
Einsele, H.
Klinker, H.
机构
关键词
D O I
10.1016/S0924-8579(07)71133-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S357 / S357
页数:1
相关论文
共 50 条
  • [41] Comparison of the clinical efficacy and safety of pantoprazole vs ranitidine over three years to prevent relapse in patients with healed erosive esophagitis
    Richter, J
    Fraga, P
    Mack, M
    Dermovsesian, A
    Nielsen, S
    Bochenek, W
    Weinstein, W
    GASTROENTEROLOGY, 2003, 124 (04) : A232 - A232
  • [42] Orally administered ranitidine plasma concentrations before and after biliopancreatic diversion in morbidly obese patients
    Cossu, ML
    Caccia, S
    Coppola, M
    Fais, E
    Ruggiu, M
    Fracasso, C
    Nacca, A
    Noya, G
    OBESITY SURGERY, 1999, 9 (01) : 36 - 39
  • [43] Orally Administered Ranitidine Plasma Concentrations before and after Biliopancreatic Diversion in Morbidly Obese Patients
    Maria Laura Cossu
    Silvio Caccia
    Massimiliano Coppola
    Enrico Fais
    Matteo Ruggiu
    Claudia Fracasso
    Angelo Nacca
    Giuseppe Noya
    Obesity Surgery, 1999, 9 : 36 - 39
  • [44] Variability in trough plasma saquinavir concentrations in HIV patients - a case for therapeutic drug monitoring
    Barry, MG
    Merry, C
    Lloyd, J
    Halifax, K
    Carey, P
    Mulcahy, F
    Back, DJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (05) : 501 - 502
  • [45] Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data
    Ding, Jing
    Zhang, Yan
    Zhang, Yan
    Yang, Liu
    Zhang, Suo
    Cui, Xiaohua
    Meng, Zhuocheng
    Li, Yajuan
    Xing, Huan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (06) : 552 - 559
  • [46] Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes
    Matsumoto, Kazuaki
    Ikawa, Kazuro
    Abematsu, Kazuko
    Fukunaga, Naoko
    Nishida, Kentaro
    Fukamizu, Tomohide
    Shimodozono, Yoshihiro
    Morikawa, Norifumi
    Takeda, Yasuo
    Yamada, Katsushi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (01) : 91 - 94
  • [47] Monitoring Voriconazole Pharmacogenomics and Plasma Concentrations in the Treatment and Prevention of Invasive Fungal Disease for Chinese Hematological Patients
    Tang, XiaoWen
    Qu, Honglan
    Guo, Dandan
    Xu, Ting
    Dai, Haiping
    Li, Zheng
    Yin, Jia
    Tian, Xiaopeng
    Guo, Danqing
    Xu, Yang
    Zhu, Xiaming
    Miao, Liyan
    Wu, Depei
    BLOOD, 2017, 130
  • [48] High-performance liquid chromatography quantitation of plasma lamotrigine concentrations: Application measuring trough concentrations in patients with epilepsy
    Sallustio, BC
    Morris, RG
    THERAPEUTIC DRUG MONITORING, 1997, 19 (06) : 688 - 693
  • [49] Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes
    Hicks, J. Kevin
    Crews, Kristine R.
    Flynn, Patricia
    Haidar, Cyrine E.
    Daniels, Calvin C.
    Yang, Wenjian
    Panetta, John C.
    Pei, Deqing
    Scott, Jeffrey R.
    Molinelli, Alejandro R.
    Broeckel, Ulrich
    Bhojwani, Deepa
    Evans, William E.
    Relling, Mary V.
    PHARMACOGENOMICS, 2014, 15 (08) : 1065 - 1078
  • [50] Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection
    Calza, L.
    Colangeli, V.
    Magistrelli, E.
    Bussini, L.
    Conti, M.
    Ramazzotti, E.
    Mancini, R.
    Viale, P.
    HIV MEDICINE, 2017, 18 (07) : 474 - 481